You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
Wrong country login message
Medical & Scientific Affairs - Areas of Interest
Areas of Interest
We are interested in study submissions involving:
The potential clinical utilities of liquid biopsies and tumor tissue in both localized and advanced stage cancers.
The relative potential clinical utility of identifying and following multiple versus single biomarkers by ctDNA and tumor tissue DNA analysis.
Applications of ctDNA analysis and tumor tissue DNA analysis that demonstrate the potential to have a big impact in cancer treatment and management.
Explore ctDNA as an indicator of minimum residual disease (MRD).
Correlate ctDNA levels and mutations with tumor volume measured by radiographic imaging across all stages.
Out of Scope
We have little interest in study submissions involving:
Studies that focus on cancer screening using circulating DNA
Studies that are in the hematological malignancy space
Strategies not incorporating Roche products
We can support studies on the following systems:
cobas z 480
AVENIO ctDNA & FFPET
Study Proposal Considerations
Does the purpose of the study align with Roche Diagnostics' medical strategy?
Is the research proposal unique and of major scientific or medical importance?
Do we have resources to support it?
Back to Areas of Interest
Some randomr randomr randomr randomr randomr randomr
To play the media you will need to either update your browser to a recent version or update your
Our policy on cookies and other tracking technologies
© 2019 Roche Diagnostics, North America